Brian McAndrews, the former CEO of digital marketing technology firm aQuantive (formerly Avenue A), is joining the world of venture capital with Seattle-based Madrona Venture Group. Madrona is announcing today that McAndrews has joined the firm as a managing director. McAndrews was chief executive of aQuantive for eight years, and he oversaw the company through … Continue reading “Former aQuantive CEO Brian McAndrews Joins Madrona Venture Group, Brings Ad Expertise”
Category: National
Seattle Genetics Recruits at Warp Speed, Amgen Passes Cancer Test, Stephen Friend’s Adventure & More Seattle-Area Life Sciences News
Quite a few publicly traded biotechs released quarterly financial statements this week, but we arranged some fascinating conversations with entrepreneurs and researchers to offset the necessary number-crunching. —Seattle Genetics is having a breakout year, and one sure sign is that it has enrolled cancer patients in a clinical trial much faster than the industry norm. … Continue reading “Seattle Genetics Recruits at Warp Speed, Amgen Passes Cancer Test, Stephen Friend’s Adventure & More Seattle-Area Life Sciences News”
Hard Work Is Essential for Startups. But How Much is Too Much? (Part 1)
Xconomy has seen a vigorous discussion of work/life balance in Seattle. Is Seattle slack compared to the San Francisco Bay Area? If so, does the difference matter? Janis Machala of UW TechTransfer brought up this point during a recent panel discussion, and it has stirred debate. I personally don’t think work/life balance is the most … Continue reading “Hard Work Is Essential for Startups. But How Much is Too Much? (Part 1)”
Alnylam, Tekmira and New Northwest Firm, AlCana, Push Boundaries of RNAi Delivery
Alnylam Pharmaceuticals is looking to the frontiers of science for ideas on how to best deliver RNA interference drugs throughout the body, and the Cambridge, MA-based company sounds most jazzed about what it sees emerging from laboratories in Vancouver, BC. Back in May, I wrote about how Alnylam—one of the richest companies in biotech—was leaning … Continue reading “Alnylam, Tekmira and New Northwest Firm, AlCana, Push Boundaries of RNAi Delivery”
VMIX Views its Online Video Service as Silver Lining for Newspaper Industry
These are dark times for the newspaper business, which has been suffering from revenue erosion as classified ads, corporate recruiting, and other forms of advertising—not to mention readers—have moved to the Internet. You’d think that means the outlook also would be gloomy at San Diego-based VMIX, a venture-backed startup that provides Web-based software used primarily … Continue reading “VMIX Views its Online Video Service as Silver Lining for Newspaper Industry”
Momenta Pharma Competitor Lodges Ethics Complaint Against FDA Boss, WSJ Reports
A story in the Wall Street Journal today about an ethics complaint against a top official at the FDA has brought new attention to Cambridge, MA-based Momenta Pharmaceuticals’ effort to win approval of its generic version of a multibillion-dollar blood thinner. The WSJ reports that Amphastar Pharmaceuticals, of Rancho Cucamonga, CA, is alleging that Momenta … Continue reading “Momenta Pharma Competitor Lodges Ethics Complaint Against FDA Boss, WSJ Reports”
Razorfish Deal Could Be Great for Microsoft, Says Online Strategy Expert Warren Gouk
One of the biggest tech deals of the year came over this past weekend—the $530 million acquisition of Seattle-based Razorfish by French marketing firm Publicis Groupe. Most people I’ve talked to seem to think the deal makes good sense for all parties. (Razorfish became an online advertising subsidiary of Microsoft in 2007 when Microsoft bought … Continue reading “Razorfish Deal Could Be Great for Microsoft, Says Online Strategy Expert Warren Gouk”
Microsoft, Nokia Announce Alliance on Smartphones
In a press conference in New York this morning, Microsoft Business Division president Stephen Elop and Nokia’s executive vice president for devices Kai Öistämö announced that Redmond, WA-based Microsoft and Finland-based Nokia have formed an alliance that will create adaptations of Microsoft programs for Nokia’s smartphones. Microsoft and Nokia will begin immediate development of Microsoft … Continue reading “Microsoft, Nokia Announce Alliance on Smartphones”
Biogen Idec Faces Suit From Partner Elan, Genzyme Wins European Approval for Stem-Cell Boosting Drug, Alnylam Teams with Tekmira, & More Boston-Area Life Sciences News
This week we had the usual mix of news on partnerships, clinical trials, and the like, as well as some fascinating in-depth discussions with key players in the life sciences arena. —Antibiotic developer Rib-X Pharmaceuticals announced that the oral form its experimental antibiotic radezolid passed a mid-stage clinical trial as a treatment for a common … Continue reading “Biogen Idec Faces Suit From Partner Elan, Genzyme Wins European Approval for Stem-Cell Boosting Drug, Alnylam Teams with Tekmira, & More Boston-Area Life Sciences News”
MIT Sloan Prof, Richard Locke, Talks Sustainability at Amazon, Intel, Nike
One of MIT’s leading business professors, Richard Locke, came to Seattle yesterday to talk about the “S” word. Yes, we’ve been hearing a lot about sustainability lately, in the context of technology and business. Big companies like Microsoft, Amazon, and Boeing are talking seriously about the issue. Smaller Seattle-area companies like Verdiem, Powerit Solutions, and … Continue reading “MIT Sloan Prof, Richard Locke, Talks Sustainability at Amazon, Intel, Nike”
Seattle Genetics, Bucking the Trend, Recruits Hodgkin’s Patients at Warp Speed
Drug companies usually have a hard time recruiting cancer patients in clinical trials, and some dirty little financial reasons for it were exposed last week in The New York Times. Another little secret is that biotech companies often overpromise, and under deliver, when they tell investors they will hit their clinical trial deadlines. That makes … Continue reading “Seattle Genetics, Bucking the Trend, Recruits Hodgkin’s Patients at Warp Speed”
Jules Pieri of The Daily Grommet Wants to Make You Think Outside the Retail Big Box
Last month I wrote about the Daily Grommet, an e-commerce startup in Lexington, MA, whose website features one cool new product or service—a “grommet,” to use the company’s term—every weekday. Far from being yet another automated online store, the Daily Grommet puts its own staff members on camera to record short, homey, informally edited videos … Continue reading “Jules Pieri of The Daily Grommet Wants to Make You Think Outside the Retail Big Box”
Avanir’s Results for Neurological Drug Triggers Outburst in Trading
The price of shares in Avanir Pharmaceuticals climbed by almost 30 percent today after the onetime San Diego biotech said a late-stage clinical trial shows its drug for treating an unusual neurological disorder can substantially reduce involuntary emotional outbursts and is “generally safe and well tolerated.” Avanir (NASDAQ: [[ticker:AVNR]]), which is now based just across the Orange … Continue reading “Avanir’s Results for Neurological Drug Triggers Outburst in Trading”
Razorfish Chief Strategy Officer Says Publicis Deal Will Expand Firm’s Global Reach
Yesterday was a busy day for Razorfish chief strategy officer Jeff Lanctot. With the official announcement that French advertising firm Publicis will acquire Microsoft-owned Razorfish, Lanctot had quite a lot on his plate. Despite his having to fly out from Seattle to another office, I managed to get a few answers from him about the … Continue reading “Razorfish Chief Strategy Officer Says Publicis Deal Will Expand Firm’s Global Reach”
Northrop Grumman Takes Center Stage at Unmanned Technologies Confab
The Association for Unmanned Vehicle Systems International says its conference and exhibition in Washington D.C. this week is the largest event of its kind, featuring the world’s biggest collection of robotic vehicles for use in the air, land, and sea. Judging by the news conference agenda, however, the four-day convention could almost be called the … Continue reading “Northrop Grumman Takes Center Stage at Unmanned Technologies Confab”
Sequenom Maintains Tight Lid on “Mishandled Data” of Key Diagnostic Test
Three months ago, San Diego’s Sequenom disclosed that the launch of a new prenatal test for Down syndrome would be delayed because scientific data had been mishandled. So what have we learned since that bombshell announcement? Not much. The company’s recent quarterly filing with the SEC suggests Sequenom (NASDAQ: [[ticker:SQNM]]) must start the process of … Continue reading “Sequenom Maintains Tight Lid on “Mishandled Data” of Key Diagnostic Test”
Alnylam Takes Moment to Pause on Cutting Edge, Mull Options on RSV Game Plan
Navigating the world of cutting-edge drug development can be thrilling, but you can sometimes find yourself in a gray zone. That’s the impression I got from a conversation yesterday with Alnylam Pharmaceuticals CEO John Maraganore about the many options he’s carefully mulling over before deciding whether to bet bigger company resources on his lead drug … Continue reading “Alnylam Takes Moment to Pause on Cutting Edge, Mull Options on RSV Game Plan”
Microsoft Sells Razorfish, EnerG2 Scores Stimulus Funds, Tekmira Teams Up with Alnylam, & More Seattle-Area Deals News
The big news of the week was Microsoft’s sale of Razorfish to Publicis (see directly below), but there were a few other important deals in software, biotech, and energy. —Microsoft’s online advertising subsidiary, Seattle-based Razorfish, was bought by French marketing firm Publicis for approximately $530 million, as Bob reported. The payment is expected to include … Continue reading “Microsoft Sells Razorfish, EnerG2 Scores Stimulus Funds, Tekmira Teams Up with Alnylam, & More Seattle-Area Deals News”
Energy Secretary Steven Chu: Hire Brash Young Turks to Create the New Bell Labs
Steven Chu was once a young turk scientist in the late 1970s at Bell Labs, the hothouse that gave the world the transistor, satellites, and all sorts of other high tech inventions. Now that he’s the U.S. Secretary of Energy, overseeing 30,000 government scientists and engineers around the country, Chu is drawing on his own … Continue reading “Energy Secretary Steven Chu: Hire Brash Young Turks to Create the New Bell Labs”
A Visit to Olin College: A Design-Oriented Future of American Engineering
[Updated and corrected, August 11—see below] Anyone who has spent much time in universities knows that openness, teamwork, and collaboration are widely taught, but not always widely practiced. And when it comes to implementing entirely new models of education, well, let’s just say that institutional barriers, turf wars, bureaucracy, and tradition all too often derail … Continue reading “A Visit to Olin College: A Design-Oriented Future of American Engineering”
Bay State Startup Investments Soared in July—Internet the Busiest Sector
Investments in Massachusetts startups rose as fast in July as the Red Sox have fallen in August. Venture investors poured some $215 million into a whopping 25 deals last month. That marked a 54 percent jump over the $139.5 million invested in 15 deals in June, according to data provided to Xconomy by ChubbyBrain, a … Continue reading “Bay State Startup Investments Soared in July—Internet the Busiest Sector”
Dendreon Will Build Manufacturing Plant in Georgia
Dendreon (NASDAQ: [[ticker:DNDN]]), the Seattle-based developer of an immune-boosting drug for prostate cancer, announced today that it has leased property in Atlanta to build a second manufacturing plant for the drug. Rumors about the deal surfaced last month, but Dendreon would not comment before the official announcement. The factory will actually be built in Union … Continue reading “Dendreon Will Build Manufacturing Plant in Georgia”
Turbine Collects $6.6M of $50M Round for Role-Playing Empire
Turbine, the Westwood, MA-based maker of online role-playing games profiled here last week, has obtained $6.57 million of a planned $50 million Series D round of financing from its venture funders, according to a document filed today with the Securities and Exchange Commission. The funding was first reported by Dan Primack at PE Hub. So … Continue reading “Turbine Collects $6.6M of $50M Round for Role-Playing Empire”
Report: Dataupia Selling Off Assets
Judging from an IDG News report published in PC World on Friday, Cambridge, MA-based Dataupia is spinning down permanently. The maker of high-speed computing appliances for handling large business datasets has gone through yet another round of staff cuts and is putting its assets up for sale, the report says. Xconomy reported in June that … Continue reading “Report: Dataupia Selling Off Assets”
Do Non-Competes Curtail Startup Investments? Brownsberger and Rowe Do A Data Dive and Kick Off A Deeper Discussion
The argument over non-compete clauses in employment agreements is front and center in most discussions over ways Massachusetts can square up better against Silicon Valley. Proponents of getting rid of non-competes argue that they curtail innovation. Fearful of getting sued when they leave their employers, so the theory goes, would-be entrepreneurs either forego starting their … Continue reading “Do Non-Competes Curtail Startup Investments? Brownsberger and Rowe Do A Data Dive and Kick Off A Deeper Discussion”
Unmanned Vehicle Makers from Boston, Seattle, and San Diego (Xconomy’s Cities) Showcase Advances at DC Confab
The world’s largest collection of unmanned aircraft and other robotic systems is coming in for a landing this week in Washington, D.C., at a four-day conference that’s sponsored by AUVSI, the Association for Unmanned Vehicle Systems International. Today’s the big day for video capture, with live demonstrations of UAVs (Unmanned Aerial Vehicles) and UGVs (Unmanned … Continue reading “Unmanned Vehicle Makers from Boston, Seattle, and San Diego (Xconomy’s Cities) Showcase Advances at DC Confab”
Green Car Company Rides Wave of Plug-in Hybrids, Battery Technologies
A lot of people modify their cars, but the alterations to the hybrid Toyota Prius I was test-driving last week were more than just a fancy paint job or cool rims. In addition to the standard regenerative braking battery, I was packing an A123 Systems Hymotion L5 lithium ion battery that charged by plugging into … Continue reading “Green Car Company Rides Wave of Plug-in Hybrids, Battery Technologies”
San Diego’s Senomyx in New Lucrative Collaboration, Google Ventures is V-Vehicle Backer, KidZui Launches ZuiTube, & Other San Diego BizTech News
There were deals to report in San Diego last week. Not necessarily big deals, but even little deals are a big deal these days. Read all about it in this week’s BizTech roundup. —The V-Vehicle Co. operated in stealth mode in San Diego for three years before it surprised many in June, when the startup … Continue reading “San Diego’s Senomyx in New Lucrative Collaboration, Google Ventures is V-Vehicle Backer, KidZui Launches ZuiTube, & Other San Diego BizTech News”
Connective Orthopaedics Wants to Improve ACL Surgeries, Taps Boston Celtics CEO as Director
Sports fans know how a knee injury ruined the last season for beloved New England Patriots quarterback Tom Brady, and many other athletes before him. Now Connective Orthopaedics , a Waltham, MA, medical devices startup, is quietly researching new products that could potentially improve recoveries for people after they undergo knee surgery. Connective CEO Dean … Continue reading “Connective Orthopaedics Wants to Improve ACL Surgeries, Taps Boston Celtics CEO as Director”
Universal Healthcare Can Save Money, But Innovation Is Key: My Experiences in Japan and the U.S.
I was born and grew up in Japan and have first-hand experience as both a doctor and a patient in my native country—a nation that offers universal health care coverage to its citizens. I have also been a patient, an academic researcher and a biotech entrepreneur here in the United States, my home for the … Continue reading “Universal Healthcare Can Save Money, But Innovation Is Key: My Experiences in Japan and the U.S.”
Amgen’s Personalized Strategy for Cancer Pays Off in Big Colon Cancer Trial
Quite a few scientists at Amgen could breathe sighs of relief over the weekend—that years of their work didn’t go down the drain. The world’s biggest biotech company, which has scientific operations in Seattle and Cambridge, MA, scored a victory in its quest to make cancer drugs tailored to specific genetic subgroups, when the idea … Continue reading “Amgen’s Personalized Strategy for Cancer Pays Off in Big Colon Cancer Trial”
Microsoft Sells Razorfish to Publicis for $530M
Microsoft’s online advertising agency Razorfish has been sold to French advertising company Publicis Groupe for approximately $530 million, the French concern announced today, confirming last week’s reports that it was bidding on Razorfish. The sale had been reported before the confirmation by the Wall Street Journal and PaidContent, and perhaps by others. Publicis said in … Continue reading “Microsoft Sells Razorfish to Publicis for $530M”
Cray, InfoSpace Exceed Analyst Expectations, and Other Second-Quarter Earnings Highlights
In the past week, companies have been releasing their financial results for the second quarter. There’s a mix of good and bad news from Seattle’s public tech companies weathering the economic storm, with surprisingly positive news from some quarters. —Bellevue, WA-based metasearch developer InfoSpace announced its revenue was $43.8 million for the quarter, up 14 … Continue reading “Cray, InfoSpace Exceed Analyst Expectations, and Other Second-Quarter Earnings Highlights”
The Shoeshine Oracles: Tech-Business Lessons from the Street
If you really want to keep your finger on the pulse of the Seattle business scene, go get your shoes shined. That’s the advice Todd Dean gave me recently. Dean is president of Keiretsu Forum Seattle/Northwest, the local chapter of the world’s largest angel investor community. He took me to see a couple of the … Continue reading “The Shoeshine Oracles: Tech-Business Lessons from the Street”
In Aftermath of Proxy Fight Amylin Pharmaceuticals Investor Expresses Concern Over Empty Board Chair Seat
After a bruising proxy battle ousted Amylin Pharmaceuticals’ chairman and lead outside director, the San Diego biotech issued a statement on June 2 that seemed to signal a cease-fire with dissident shareholders (including Carl Icahn). “We look forward to working with all our new directors to bring transformational medicines to patients and to drive sustainable … Continue reading “In Aftermath of Proxy Fight Amylin Pharmaceuticals Investor Expresses Concern Over Empty Board Chair Seat”
IPS Group, a Cellular Equipment Firm, Raising $1.5 Million in Shift to Parking Meter Business
The IPS Group, a specialized San Diego cellular technology company, is raising $1.5 million in funding from individual investors as part of a shift to the development of high-tech parking meters. The privately held company has raised more than $1.3 million so far, according to a recent filing with the Securities and Exchange Commission. The … Continue reading “IPS Group, a Cellular Equipment Firm, Raising $1.5 Million in Shift to Parking Meter Business”
Akamai And Delve Dig Into Online Video, Cardiorobotics Snags $11.6M for Snake-Like Surgery Robot, Longworth Collects $122M, & More Boston-Area Deals News
New England tech and life sciences firms forged several interesting new partnerships this week. —Apperian, a Boston-based startup developing enterprise-oriented iPhone applications, raised $1 million in a Series A venture round led by CommonAngels of Lexington, MA. —Cambridge, MA-based Akamai (NASDAQ: [[ticker:AKAM]]) teamed with Seattle’s Delve Networks to provide a new online platform for publishing … Continue reading “Akamai And Delve Dig Into Online Video, Cardiorobotics Snags $11.6M for Snake-Like Surgery Robot, Longworth Collects $122M, & More Boston-Area Deals News”
Vertex Drug Could Be “Man on the Moon” for Cystic Fibrosis Therapy, Says Researcher Bonnie Ramsey
Bonnie Ramsey remembers the dark days of treatment for cystic fibrosis. About 30 years ago, when she devoted her career to the research and treatment of this genetic lung disease, children who were diagnosed had a life expectancy of about 17 years. The outlook is much brighter for patients now, as quality of life has … Continue reading “Vertex Drug Could Be “Man on the Moon” for Cystic Fibrosis Therapy, Says Researcher Bonnie Ramsey”
Biotech Startup Acetylon Pharma Catches $7.25M in A Round from Backers Such As New England Patriots Owner
[Correction appended—08/11/09] Acetylon Pharmaceuticals is unveiling its technology today after closing a $7.25 million Series A round of financing to develop novel drugs to treat multiple myeloma and rheumatoid arthritis, according to the company. Many of the startup’s backers have close ties to the Dana-Farber Cancer Institute in Boston—including the company that owns the NFL’s … Continue reading “Biotech Startup Acetylon Pharma Catches $7.25M in A Round from Backers Such As New England Patriots Owner”
Microsoft Researchers Present Next-Gen Graphics and Software Tools at SIGGRAPH
If you want to glimpse the future of gaming and entertainment software, check out the presentations at the world’s largest and most prestigious graphics conference. This week, at the annual SIGGRAPH meeting (in New Orleans this year), researchers from Microsoft and elsewhere are presenting cutting-edge techniques in computer animation, image and video processing, interactive interfaces, … Continue reading “Microsoft Researchers Present Next-Gen Graphics and Software Tools at SIGGRAPH”
Elan Hits Biogen Idec with Lawsuit to Protect Tysabri Deal with J&J
Relations appear to be increasingly strained between Biogen Idec (NASDAQ:[[ticker:BIIB]]) and the Irish drug company Elan, its partner for the distribution and development of the multiple sclerosis drug natalizumab (Tysabri). Elan said today that it has filed suit against Biogen over the Cambridge, MA-based biotech firm’s objections to Elan’s deal announced last month with affiliates … Continue reading “Elan Hits Biogen Idec with Lawsuit to Protect Tysabri Deal with J&J”
Stephen Friend, Leaving High-Powered Merck Gig, Lights Fire for Open Source Biology Movement
Stephen Friend had it all at Merck. The lucrative salary, the national media fame, the respect of peers, the power to snap his fingers and command a corporate army of some of the brightest minds in biomedicine. This year, he gave it all up for a startup dream. Friend, 54, is best known in Seattle … Continue reading “Stephen Friend, Leaving High-Powered Merck Gig, Lights Fire for Open Source Biology Movement”
Alnylam and Tekmira Seek New Ways to Deliver RNAi Drugs Deep in the Body
(Updated: 1:20 pm ET with new commentary from Alnylam’s CEO.) Alnylam Pharmaceuticals and Tekmira Pharmaceuticals announced today that they have teamed up to develop new particles to deliver RNA-interference drugs. Their joint effort aims to identify new ways to overcome the hurdles that the gene-modulating drugs must clear to reach diseased cells deep in the … Continue reading “Alnylam and Tekmira Seek New Ways to Deliver RNAi Drugs Deep in the Body”
Isis Prepares Novel Treatment for Lou Gehrig’s Disease, BrainCells Is Encouraged by New Drug for Depression, Inovio Raises $30M, & More San Diego Life Sciences News
It might be the dog days of summer, but San Diego’s life sciences companies kept up a busy flow of cool news over the past week. Get your update here. —Isis Pharmaceuticals, the Carlsbad, CA, biotech that specializes in so-called antisense technology, is getting ready to test a new treatment later this year for patients … Continue reading “Isis Prepares Novel Treatment for Lou Gehrig’s Disease, BrainCells Is Encouraged by New Drug for Depression, Inovio Raises $30M, & More San Diego Life Sciences News”
AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News
Some of the lesser-known names in Seattle life sciences made some noise this week, just when we here at the Xconomy biotech desk thought things might slow down a tad in the dog days of summer. —AVI Biopharma (NASDAQ: [[ticker:AVII]]), the Portland, OR-based maker of RNA-based therapies, is now getting a new tagline as the … Continue reading “AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News”
Protecting America’s Leadership in Biotech Discovery
Health care reform took a turn for the better when members of key committees in both the U.S. Senate and House of Representatives recently recommended an approval pathway for biosimilars—products that attempt to be similar to an innovator biologic drug—while also preserving the hope for future medical treatments. Specifically, the committees agreed that to preserve … Continue reading “Protecting America’s Leadership in Biotech Discovery”
Cardiorobotics, Developer of Snake Robot Technology, Aims to Alter Cardiac Surgery
The future of heart surgery is in something called a “snake robot,” at least according to the people at Newport, RI-based Cardiorobotics. We decided to check it out in more depth since Cardiorobotics just raised $11.6 million this week to see if it can demonstrate this is truly the next frontier in minimally invasive ways … Continue reading “Cardiorobotics, Developer of Snake Robot Technology, Aims to Alter Cardiac Surgery”
Google Ventures Emerges as Investor in San Diego’s V-Vehicle Co.
Google Ventures has joined Silicon Valley’s Kleiner Perkins Caufield & Byers as an investor in V-Vehicle Co., the San Diego-based startup automaker developing a new line of fuel-efficient cars. The company plans to build its cars in northeastern Louisiana. Joe Fisher, a New York spokesman for the San Diego startup automaker, confirmed the corporate venture … Continue reading “Google Ventures Emerges as Investor in San Diego’s V-Vehicle Co.”
EnerG2 Wins $21.3M in Stimulus Funding to Build Ultracapacitor Materials Plant in Oregon
Seattle-based EnerG2, an advanced materials startup focused on energy storage, has scored a $21.3 million grant from the U.S. Department of Energy to build a new manufacturing plant in Albany, OR. The funds are part of a total of $2.4 billion in federal stimulus grants announced today to speed up the manufacturing and development of … Continue reading “EnerG2 Wins $21.3M in Stimulus Funding to Build Ultracapacitor Materials Plant in Oregon”
Up to 2,600 Jobs That Won’t Be Coming to MA—Boston-Power CEO “Incredibly Disappointed” to Miss Out on DOE Funds
Boston-Power CEO Christina Lampe-Onnerud says she was “incredibly disappointed” and “frankly a little surprised” when the U.S. Department of Energy today announced $1.5 billion in battery-related grants—and none of it went to her company. The Westborough, MA-based firm had requested $100 million to build a state-of-the-art “green” battery-manufacturing plant in Auburn, MA. “I have this … Continue reading “Up to 2,600 Jobs That Won’t Be Coming to MA—Boston-Power CEO “Incredibly Disappointed” to Miss Out on DOE Funds”